Skip to content

Clinical trials

Withdrawn Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Status: Withdrawn Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20071
20102
20121
20132
20142
20151
20161
20171
20182
20192
20201
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Masonic Cancer Center, University of Minnesota3
Jazz Pharmaceuticals2
Baptist Health South Florida1
Children's Hospital of Eastern Ontario1
City of Hope Medical Center1
Institute of Hematology & Blood Diseases Hospital, China1
Ludwig-Maximilians - University of Munich1
Matinas BioPharma Nanotechnologies, Inc.1
Mesoblast International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma22
Burkitt Lymphoma9
Leukemia, Myeloid, Acute9
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma6
Leukemia5
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Mantle-Cell5
Lymphoma, Non-Hodgkin5

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.